Site Search
Use small fonts Use medium fonts Use large fonts Email link to page


Related expertise

Cassels Brock Represents Canaccord Genuity in Khiron's $12.93 Million Financing

Published: 09/12/2018

Team: Nancy Choi, Stefan Politano, Christopher B. Norton

On September 12, 2018, Khiron Life Sciences Corp. completed a best efforts short form prospectus offering of common shares, including the exercise in full of the over-allotment option. A total of 14,375,000 common shares were sold at a price of $0.90 per common share for aggregate gross proceeds of approximately $12.9 million.

The offering was completed by a syndicate of agents led by Canaccord Genuity Corp., and including GMP Securities L.P., Sprott Private Wealth LP and Cormark Securities Inc.

Cassels Brock acted for Canaccord Genuity with a deal team that included Nancy Choi and Stefan Politano (Securities and Cannabis) and Chris Norton (Tax).